Nowadays, the most likely marker of platinum resistance is bone morphologenetic protein 2 (BMP2), which is upregulated in ovarian cancer cells, and which is correlated with poor prognosis23, 24. This evidence concerns the gene BMP2 and ovarian carcinoma.